Safety, Tolerability, and Pharmacokinetics of Anti-SARS-CoV-2 Immunoglobulin Intravenous (Human) Investigational Product (COVID-HIGIV) in Healthy Adults: a Randomized, Controlled, Double-Blinded, Phase 1 Study

Anti-SARS-CoV-2 immunoglobulin (human) investigational product (COVID-HIGIV) is a purified immunoglobulin preparation containing SARS-CoV-2 polyclonal antibodies. This single-center clinical trial aimed to characterize the safety and pharmacokinetics of COVID-HIGIV in healthy, adult volunteers. Part...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Sean T. H., Mirceta, Mila, Lin, Grace, Anderson, Deborah M., Broomes, Tarashon, Jen, Alina, Abid, Ashley, Reich, David, Hall, Christine, Aberg, Judith A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2023
Materias:
Antiviral Agents
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10019156/
https://www.ncbi.nlm.nih.gov/pubmed/36852998
http://dx.doi.org/10.1128/aac.01514-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10019156/
https://www.ncbi.nlm.nih.gov/pubmed/36852998
http://dx.doi.org/10.1128/aac.01514-22

Ejemplares similares